Advertisement
Advertisement

NKTX

NKTX logo

Nkarta, Inc. Common Stock

2.21
USD
Sponsored
-0.22
-8.85%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

2.22

+0.01
+0.23%

NKTX Earnings Reports

Positive Surprise Ratio

NKTX beat 12 of 22 last estimates.

55%

Next Report

Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.33
Implied change from Q3 25 (Revenue/ EPS)
--
/
+17.86%
Implied change from Q1 25 (Revenue/ EPS)
--
/
-23.26%

Nkarta, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, NKTX reported earnings of -0.28 USD per share (EPS) for Q3 25, beating the estimate of -0.31 USD, resulting in a 9.26% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.55% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of -0.33 USD, with revenue projected to reach -- USD, implying an increase of 17.86% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Nkarta, Inc. Common Stock reported EPS of -$0.28, beating estimates by 9.26%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.55%, changed from $1.96 before the earnings release to $2.01 the day after.
The next earning report is scheduled for May 12, 2026.
Based on 6 analysts, Nkarta, Inc. Common Stock is expected to report EPS of -$0.33 and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement